CStone Pharmaceuticals (HKG:2616)
Hong Kong
· Delayed Price · Currency is HKD 6.94
+0.46 (7.10%)
Mar 10, 2026, 1:15 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 9.54 billion as of March 9, 2026. Its market cap has increased by 176.80% in one year.
Market Cap
9.54B
Enterprise Value
9.21B
Revenue
221.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.94
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 9.54B, a decrease of -24.61%. That is a compound annual growth rate of -3.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haohai Biological Technology | 9.96B |
| HBM Holdings | 10.08B |
| Nanjing Leads Biolabs | 10.71B |
| Guangzhou Innogen Pharmaceutical Group | 11.05B |
| Abbisko Cayman | 7.99B |
| Lepu Biopharma | 7.92B |
| Alphamab Oncology | 7.60B |
| CK Life Sciences Int'l., (Holdings) | 7.59B |